Skip to main content

2024 ISPE Annual Meeting Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Spotlight Session - Drug-Drug Interaction

Spotlight Session - Drug-Drug Interaction

Type here to filter the list

(ASPOT25) Drug-Drug Interactions Between Direct-Acting Oral Anticoagulants and Antiseizure Medications: A Target Trial Emulation

Favorite
(ASPOT26) Effect of drug-drug interactions involving direct-acting oral anticoagulants and statins on the risk of bleeding

Favorite
(ASPOT27) Risk of thyroid dysfunction associated with the concomitant use of amiodarone and sulfonylureas: a nationwide cohort study

Favorite
(ASPOT28) The Economic Burden of Drug-Drug Interactions in an Older Population acutely admitted to Hospital in Ireland: A Propensity Score Pharmacoeconomic Analysis.

Favorite
(ASPOT29) Drug-Drug Interactions in the Older Community-Dwelling Population: Findings from The Irish LongituDinal study on Ageing

Favorite
(ASPOT30) The prevalent new-user design to study drug-drug interactions: the example of sulfonylureas and warfarin interaction on the risk of severe hypoglycemia

Favorite
(ASPOT31) Trends in the Concurrent Use of Illicit Drugs and Interacting Prescription Medications Among Adults in the United States

Favorite
(ASPOT32) Concomitant use of direct oral anticoagulants and pharmacokinetically-interacting antiarrhythmics and the risk of major bleeding in patients with non-valvular atrial fibrillation: population-based cohort study

Favorite